Martin Gouldstone
Vorstandsvorsitzender bei ONCIMMUNE HOLDINGS PLC
Vermögen: 10 420 $ am 30.04.2024
Aktive Positionen von Martin Gouldstone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HVIVO PLC | Direktor/Vorstandsmitglied | 08.06.2022 | - |
Independent Dir/Board Member | 08.06.2022 | - | |
ONCIMMUNE HOLDINGS PLC | Direktor/Vorstandsmitglied | 01.08.2023 | - |
Vorstandsvorsitzender | 01.08.2023 | - | |
HVIVO PLC | Direktor/Vorstandsmitglied | 01.06.2022 | - |
Independent Dir/Board Member | 01.06.2022 | - | |
VALIRX PLC | Direktor/Vorstandsmitglied | 29.02.2024 | - |
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Corporate Officer/Principal | - | - |
Karriereverlauf von Martin Gouldstone
Ehemalige bekannte Positionen von Martin Gouldstone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SENSYNE HEALTH PLC | Corporate Officer/Principal | 01.03.2021 | 01.05.2022 |
Results Healthcare
Results Healthcare Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Results Healthcare is a British company that provides advisory services. | Corporate Officer/Principal | 01.01.2017 | 01.06.2018 |
BDO UK LLP
BDO UK LLP Miscellaneous Commercial ServicesCommercial Services BDO UK LLP provides tax, audit & assurance, advisory and business outsourcing services. The private company is based in London, UK. | Corporate Officer/Principal | 01.01.2014 | 01.01.2017 |
BENEVOLENTAI | Corporate Officer/Principal | - | - |
░░░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Statistik
International
Vereinigtes Königreich | 11 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 6 |
Director/Board Member | 6 |
Independent Dir/Board Member | 2 |
Sektoral
Commercial Services | 6 |
Health Technology | 4 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
SENSYNE HEALTH PLC | Commercial Services |
HVIVO PLC | Commercial Services |
ONCIMMUNE HOLDINGS PLC | Health Technology |
VALIRX PLC | Health Technology |
BENEVOLENTAI | Health Technology |
Private Unternehmen | 6 |
---|---|
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Retail Trade |
Owkin, Inc.
Owkin, Inc. Packaged SoftwareTechnology Services Owkin, Inc. operates as an artificial intelligence company. It develops software which allow prediction modeling and population comparison services. The firm's products include OWKIN Socrates and OWKIN Services. The company was founded by Thomas Clozel and Gilles Wainrib in 2016 and is headquartered in Albany, NY. | Technology Services |
Orthopaedic Research UK
Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Orthopaedic Research UK provides business support services. The non-profit company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 1989 by Ronald John Furlong. Arash Angadji has been the CEO of the company since 2008. | Commercial Services |
Results Healthcare
Results Healthcare Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Results Healthcare is a British company that provides advisory services. | Finance |
BDO UK LLP
BDO UK LLP Miscellaneous Commercial ServicesCommercial Services BDO UK LLP provides tax, audit & assurance, advisory and business outsourcing services. The private company is based in London, UK. | Commercial Services |
hVIVO Ltd.
hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Martin Gouldstone
- Erfahrung